Skip to Main Content

Author Details

Sourav Bandyopadhyay
University of California San Francisco
2004
49
29
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37264081A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer.Oncogene2023
37384294Computational drug repositioning for the identification of new agents to sensitize drug-resistant breast tumors across treatments and receptor subtypes.Front Oncol2023
36052495Editor's Note: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
36276634Trans-channel fluorescence learning improves high-content screening for Alzheimer's disease therapeutics.Nat Mach Intell2022
36144235Novel Regulators of Macropinocytosis-Dependent Growth Revealed by Informer Set Library Screening in Pancreatic Cancer Cells.Metabolites2022
36052496Correction: Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2022
32603749Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Kα/δ and HDAC.J Invest Dermatol2021
33639398Aurora kinases shed light on resistance to EGFR inhibition in head and neck cancer.EBioMedicine2021
34261774Correction: Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> Patients.Clin Cancer Res2021
34330832UDP-glucose pyrophosphorylase 2, a regulator of glycogen synthesis and glycosylation, is critical for pancreatic cancer growth.Proc Natl Acad Sci U S A2021
32398776Integration of multiple biological contexts reveals principles of synthetic lethality that affect reproducibility.Nat Commun2020
32822576Therapy-Induced Evolution of Human Lung Cancer Revealed by Single-Cell RNA Sequencing.Cell2020
32847978<i>Nf1</i>-Mutant Tumors Undergo Transcriptome and Kinome Remodeling after Inhibition of either mTOR or MEK.Mol Cancer Ther2020
30478424Aurora kinase A drives the evolution of resistance to third-generation EGFR inhibitors in lung cancer.Nat Med2019
31528688Targeting the evolution of drug resistance in lung cancer.Mol Cell Oncol2019
29440171Cross-talk Signaling between HER3 and HPV16 E6 and E7 Mediates Resistance to PI3K Inhibitors in Head and Neck Cancer.Cancer Res2018
29942081Kinome rewiring reveals AURKA limits PI3K-pathway inhibitor efficacy in breast cancer.Nat Chem Biol2018
30414925Integration of Tumor Genomic Data with Cell Lines Using Multi-dimensional Network Modules Improves Cancer Pharmacogenomics.Cell Syst2018
29669295A Quantitative Chemotherapy Genetic Interaction Map Reveals Factors Associated with PARP Inhibitor Resistance.Cell Rep2018
29359686Targeting RAS-driven human cancer cells with antibodies to upregulated and essential cell-surface proteins.Elife2018
27986750Human Papillomavirus Regulates HER3 Expression in Head and Neck Cancer: Implications for Targeted HER3 Therapy in HPV<sup>+</sup> Patients.Clin Cancer Res2017
27380425Protein Sialylation Regulates a Gene Expression Signature that Promotes Breast Cancer Cell Pathogenicity.ACS Chem Biol2016
27364904Synthetic Lethal Targeting of ARID1A-Mutant Ovarian Clear Cell Tumors with Dasatinib.Mol Cancer Ther2016
27417679Challenges in identifying cancer genes by analysis of exome sequencing data.Nat Commun2016
25501949Linking tumor mutations to drug responses via a quantitative chemical-genetic interaction map.Cancer Discov2015
25843712NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer.Cell Rep2015
25945974Activity-Based Protein Profiling of Oncogene-Driven Changes in Metabolism Reveals Broad Dysregulation of PAFAH1B2 and 1B3 in Cancer.ACS Chem Biol2015
25977330Enhanced MET Translation and Signaling Sustains K-Ras-Driven Proliferation under Anchorage-Independent Growth Conditions.Cancer Res2015
24302555Epithelial-to-mesenchymal transition rewires the molecular path to PI3K-dependent proliferation.Cancer Discov2014
25127139Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors.Cell Rep2014
24738946Inositol phosphate recycling regulates glycolytic and lipid metabolism that drives cancer aggressiveness.ACS Chem Biol2014
24550319Mapping the molecular determinants of BRAF oncogene dependence in human lung cancer.Proc Natl Acad Sci U S A2014
23407553Quantitative genetic-interaction mapping in mammalian cells.Nat Methods2013
23719353Bringing it all together: big data and HIV research.AIDS2013
20027183Human host factors required for influenza virus replication.Nature2010
21127252Rewiring of genetic networks in response to DNA damage.Science2010
20978140Coevolution within a transcriptional network by compensatory trans and cis mutations.Genome Res2010
20936779A human MAP kinase interactome.Nat Methods2010
19478882Host cell factors in HIV replication: meta-analysis of genome-wide studies.PLoS Pathog2009
19730696Evolutionarily conserved herpesviral protein interaction networks.PLoS Pathog2009
18421374Functional maps of protein complexes from quantitative genetic interaction data.PLoS Comput Biol2008
18854154Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.Cell2008
18818364Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast.Science2008
19061648A genetic interaction map of RNA-processing factors reveals links between Sem1/Dss1-containing complexes and mRNA export and splicing.Mol Cell2008
17703239Integrating physical and genetic maps: from genomes to interaction networks.Nat Rev Genet2007
16510899Systematic identification of functional orthologs based on protein network comparison.Genome Res2006
17094252Discovering regulated networks during HIV-1 latency and reactivation.Pac Symp Biocomput2006
15070401Evolutionary and functional relationships within the DJ1 superfamily.BMC Evol Biol2004
15181200The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization.Proc Natl Acad Sci U S A2004
  • 1 - 49 of 49

Recommended Authors

Brent M Kuenzi
Moffitt Cancer Center
Career Start Year 2014
Number of shared co-authors 4
Marco Mina
University of Lausanne, Switzerland Swiss Cancer Center Leman
Career Start Year 2012
Number of shared co-authors 2
Frederick S Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2010
Number of shared co-authors 0
Nidhi Sahni
The University of Texas MD Anderson Cancer Center
Career Start Year 2008
Number of shared co-authors 0
J??ri Reimand
Ontario Institute for Cancer Research
Career Start Year 2007
Number of shared co-authors 1
Siyuan Zheng
Greehey Children's Cancer Research Institute
Career Start Year 2007
Number of shared co-authors 1
James C Costello
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 2
Christopher A Bristow
The University of Texas MD Anderson Cancer Center
Career Start Year 2005
Number of shared co-authors 4
Armand Bankhead
Rogel Cancer Center, University of Michigan ann arbor
Career Start Year 2005
Number of shared co-authors 0
Jesse S Boehm
Broad Institute of Harvard and MIT
Career Start Year 2004
Number of shared co-authors 5
Adam A Margolin
Icahn School of Medicine
Career Start Year 2004
Number of shared co-authors 8
Andrey Sivachenko
Cystic Fibrosis Foundation
Career Start Year 2003
Number of shared co-authors 4
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 2
Rune Linding
Humboldt-Universitat zu Berlin
Career Start Year 2002
Number of shared co-authors 3
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Franco J Vizeacoumar
College of Medicine, University of Saskatchewan
Career Start Year 2002
Number of shared co-authors 3
Mariano J Alvarez
Vagelos College of Physicians and Surgeons, Columbia University Irving Medical Center
Career Start Year 2000
Number of shared co-authors 6
Kevin R Brown
College Street, University of Toronto
Career Start Year 2000
Number of shared co-authors 0
Joshua M Stuart
University of California at Santa Cruz
Career Start Year 2000
Number of shared co-authors 10
Colm J Ryan
University College Dublin
Career Start Year 1999
Number of shared co-authors 18
Igor Jurisica
Schroeder Arthritis Institute
Career Start Year 1998
Number of shared co-authors 0
Jason Moffat
University of Toronto
Career Start Year 1997
Number of shared co-authors 3
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 1
Michael A White
University of Georgia
Career Start Year 1994
Number of shared co-authors 7
David E Root
Broad Institute of Harvard and MIT
Career Start Year 1993
Number of shared co-authors 12
Andrea Califano
Columbia University
Career Start Year 1993
Number of shared co-authors 12
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 13
Pablo Tamayo
University of California San Diego
Career Start Year 1988
Number of shared co-authors 11
William C Hahn
Broad Institute of MIT and Harvard, USA Dana-Farber Cancer Institute
Career Start Year 1987
Number of shared co-authors 9
Francisca Vazquez
Broad Institute of MIT and Harvard
Career Start Year 1979
Number of shared co-authors 4

Collaborators

Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 14
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 12
Frank McCormick
Frederick National Laboratory for Cancer Research
Co-authored papers 9
Andrei Goga
University of California San Francisco
Co-authored papers 6
Neil E Bhola
Zai Lab (US) LLC
Co-authored papers 5
Michael Shales
University of California, USA Quantitative Biosciences Institute (QBI) san francisco
Co-authored papers 5
Stefan Hartmann
University Hospital Wurzburg
Co-authored papers 5
Sumit K Chanda
The Scripps Research Institute
Co-authored papers 5
Toni M Brand
University of Wisconsin School of Medicine and Public Health
Co-authored papers 5
Umamaheswar Duvvuri
University of Pittsburgh School of Medicine
Co-authored papers 5
Daniel E Johnson
University of California San Francisco
Co-authored papers 5
Kevan M Shokat
University of California San Francisco
Co-authored papers 5
Max V Ranall
University of California San Francisco
Co-authored papers 5
Jennifer R Grandis
University of California san francisco
Co-authored papers 5
Yan Zeng
Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College
Co-authored papers 5
Theresa M LaVallee
Parker Institute for Cancer Immunotherapy
Co-authored papers 5
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Co-authored papers 4
Jonathan S Weissman
Whitehead Institute for Biomedical Research
Co-authored papers 4
Trever G Bivona
University of California san francisco
Co-authored papers 4
James T Webber
Broad Institute of Harvard and MIT
Co-authored papers 4
Rebecca S Levin
Howard Hughes Medical Institute, University of California San Francisco
Co-authored papers 4
John A T Young
Roche Pharma
Co-authored papers 4
Collin M Blakely
University of California san francisco
Co-authored papers 3
Frederic D Bushman
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 3
Julie E Bauman
George Washington University
Co-authored papers 3
Carolyn Kemp
University of Pittsburgh Medical Center, Eye and Ear Institute
Co-authored papers 3
Antonio Sorrentino
Leibniz Institute for Immunotherapy (LIT)
Co-authored papers 3
Michelle A Ozbun
The University of New Mexico School of Medicine
Co-authored papers 3
Daniel K Nomura
University of California berkeley
Co-authored papers 3
Renate K??nig
Paul-Ehrlich-Institut
Co-authored papers 3
Release 1.2